APO RESEARCH · REPORT
Artemisinin
Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.
Product & engineering
Understand the product.
Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.
Selected research
Market Structure
Global Artemisinin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.
Global Artemisinin key players include KPC Pharmaceuticals, Kerui nanhai, Sanofi, Guangxi xiancaotang, etc. Global top four manufacturers hold a share over 65%.
Europe is the largest market, with a share about 45%, followed by India, and Africa, both have a share about 40 percent.
Read the full market overview
In terms of product, Extraction from Artemisia annua is the largest segment, with a share over 80%. And in terms of application, the largest application is Antimalarial Tablets, followed by Antimalarial Injections.
The report provides an overview of the global Artemisinin market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Artemisinin and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Artemisinin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Artemisinin market size, projected growth trends, production technologies, key applications, and end-use industries.
Artemisinin Segment by Company
Sanofi
KPC Pharmaceuticals
Kerui nanhai
Guangxi xiancaotang
Guilin Pharmaceutical
Natural Bio-engineering
BIONEXX
CAT KHANH
BEEPZ
Novanat Bioresource
Artemisinin Segment by Type
Extraction From Artemisia Annua
Semisynthetic Artemisinin
Artemisinin Segment by Application
Antimalarial Injections
Antimalarial Tablets
Artemisinin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artemisinin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artemisinin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artemisinin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Artemisinin market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artemisinin industry.
Chapter 3: Detailed analysis of Artemisinin market competition landscape. Including Artemisinin manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Artemisinin by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Artemisinin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Extraction From Artemisia Annua
- Semisynthetic Artemisinin
Applications
- Antimalarial Injections
- Antimalarial Tablets
Companies covered
- Sanofi
- KPC Pharmaceuticals
- Kerui nanhai
- Guangxi xiancaotang
- Guilin Pharmaceutical
- Natural Bio-engineering
- BIONEXX
- CAT KHANH
- BEEPZ
- Novanat Bioresource
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Artemisinin Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Artemisinin Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Artemisinin Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Artemisinin Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Artemisinin Market Dynamics
- 2.1 Artemisinin Industry Trends
- 2.2 Artemisinin Industry Drivers
- 2.3 Artemisinin Industry Opportunities and Challenges
- 2.4 Artemisinin Industry Restraints
3 Artemisinin Market by Manufacturers
- 3.1 Global Artemisinin Production Value by Manufacturers (2021-2026)
- 3.2 Global Artemisinin Production by Manufacturers (2021-2026)
- 3.3 Global Artemisinin Average Price by Manufacturers (2021-2026)
- 3.4 Global Artemisinin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Artemisinin Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Artemisinin Manufacturers, Product Type & Application
- 3.7 Global Artemisinin Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Artemisinin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Artemisinin Players Market Share by Production Value in 2025
- 3.8.3 2025 Artemisinin Tier 1, Tier 2, and Tier 3
4 Artemisinin Market by Type
- 4.1 Artemisinin Type Introduction
- 4.1.1 Extraction From Artemisia Annua
- 4.1.2 Semisynthetic Artemisinin
- 4.2 Global Artemisinin Production by Type
- 4.2.1 Global Artemisinin Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Artemisinin Production by Type (2021-2032)
- 4.2.3 Global Artemisinin Production Market Share by Type (2021-2032)
- 4.3 Global Artemisinin Production Value by Type
- 4.3.1 Global Artemisinin Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Artemisinin Production Value by Type (2021-2032)
- 4.3.3 Global Artemisinin Production Value Market Share by Type (2021-2032)
5 Artemisinin Market by Application
- 5.1 Artemisinin Application Introduction
- 5.1.1 Antimalarial Injections
- 5.1.2 Antimalarial Tablets
- 5.2 Global Artemisinin Production by Application
- 5.2.1 Global Artemisinin Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Artemisinin Production by Application (2021-2032)
- 5.2.3 Global Artemisinin Production Market Share by Application (2021-2032)
- 5.3 Global Artemisinin Production Value by Application
- 5.3.1 Global Artemisinin Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Artemisinin Production Value by Application (2021-2032)
- 5.3.3 Global Artemisinin Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Sanofi
- 6.1.1 Sanofi Company Information
- 6.1.2 Sanofi Business Overview
- 6.1.3 Sanofi Artemisinin Production, Value and Gross Margin (2021-2026)
- 6.1.4 Sanofi Artemisinin Product Portfolio
- 6.1.5 Sanofi Recent Developments
- 6.2 KPC Pharmaceuticals
- 6.2.1 KPC Pharmaceuticals Company Information
- 6.2.2 KPC Pharmaceuticals Business Overview
- 6.2.3 KPC Pharmaceuticals Artemisinin Production, Value and Gross Margin (2021-2026)
- 6.2.4 KPC Pharmaceuticals Artemisinin Product Portfolio
- 6.2.5 KPC Pharmaceuticals Recent Developments
- 6.3 Kerui nanhai
- 6.3.1 Kerui nanhai Company Information
- 6.3.2 Kerui nanhai Business Overview
- 6.3.3 Kerui nanhai Artemisinin Production, Value and Gross Margin (2021-2026)
- 6.3.4 Kerui nanhai Artemisinin Product Portfolio
- 6.3.5 Kerui nanhai Recent Developments
- 6.4 Guangxi xiancaotang
- 6.4.1 Guangxi xiancaotang Company Information
- 6.4.2 Guangxi xiancaotang Business Overview
- 6.4.3 Guangxi xiancaotang Artemisinin Production, Value and Gross Margin (2021-2026)
- 6.4.4 Guangxi xiancaotang Artemisinin Product Portfolio
- 6.4.5 Guangxi xiancaotang Recent Developments
- 6.5 Guilin Pharmaceutical
- 6.5.1 Guilin Pharmaceutical Company Information
- 6.5.2 Guilin Pharmaceutical Business Overview
- 6.5.3 Guilin Pharmaceutical Artemisinin Production, Value and Gross Margin (2021-2026)
- 6.5.4 Guilin Pharmaceutical Artemisinin Product Portfolio
- 6.5.5 Guilin Pharmaceutical Recent Developments
- 6.6 Natural Bio-engineering
- 6.6.1 Natural Bio-engineering Company Information
- 6.6.2 Natural Bio-engineering Business Overview
- 6.6.3 Natural Bio-engineering Artemisinin Production, Value and Gross Margin (2021-2026)
- 6.6.4 Natural Bio-engineering Artemisinin Product Portfolio
- 6.6.5 Natural Bio-engineering Recent Developments
- 6.7 BIONEXX
- 6.7.1 BIONEXX Company Information
- 6.7.2 BIONEXX Business Overview
- 6.7.3 BIONEXX Artemisinin Production, Value and Gross Margin (2021-2026)
- 6.7.4 BIONEXX Artemisinin Product Portfolio
- 6.7.5 BIONEXX Recent Developments
- 6.8 CAT KHANH
- 6.8.1 CAT KHANH Company Information
- 6.8.2 CAT KHANH Business Overview
- 6.8.3 CAT KHANH Artemisinin Production, Value and Gross Margin (2021-2026)
- 6.8.4 CAT KHANH Artemisinin Product Portfolio
- 6.8.5 CAT KHANH Recent Developments
- 6.9 BEEPZ
- 6.9.1 BEEPZ Company Information
- 6.9.2 BEEPZ Business Overview
- 6.9.3 BEEPZ Artemisinin Production, Value and Gross Margin (2021-2026)
- 6.9.4 BEEPZ Artemisinin Product Portfolio
- 6.9.5 BEEPZ Recent Developments
- 6.10 Novanat Bioresource
- 6.10.1 Novanat Bioresource Company Information
- 6.10.2 Novanat Bioresource Business Overview
- 6.10.3 Novanat Bioresource Artemisinin Production, Value and Gross Margin (2021-2026)
- 6.10.4 Novanat Bioresource Artemisinin Product Portfolio
- 6.10.5 Novanat Bioresource Recent Developments
7 Global Artemisinin Production by Region
- 7.1 Global Artemisinin Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Artemisinin Production by Region (2021-2032)
- 7.2.1 Global Artemisinin Production by Region (2021-2026)
- 7.2.2 Global Artemisinin Production Forecast by Region (2027-2032)
- 7.3 Global Artemisinin Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Artemisinin Production Value by Region (2021-2032)
- 7.4.1 Global Artemisinin Production Value by Region (2021-2026)
- 7.4.2 Global Artemisinin Production Value by Region (2027-2032)
- 7.5 Global Artemisinin Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Artemisinin Production Value (2021-2032)
- 7.6.2 Europe Artemisinin Production Value (2021-2032)
- 7.6.3 Asia-Pacific Artemisinin Production Value (2021-2032)
- 7.6.4 South America Artemisinin Production Value (2021-2032)
- 7.6.5 Middle East & Africa Artemisinin Production Value (2021-2032)
8 Global Artemisinin Consumption by Region
- 8.1 Global Artemisinin Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Artemisinin Consumption by Region (2021-2032)
- 8.2.1 Global Artemisinin Consumption by Region (2021-2026)
- 8.2.2 Global Artemisinin Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Artemisinin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Artemisinin Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Artemisinin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Artemisinin Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Artemisinin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Artemisinin Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Artemisinin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Artemisinin Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Artemisinin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Artemisinin Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Artemisinin Value Chain Analysis
- 9.1.1 Artemisinin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Artemisinin Production Mode & Process
- 9.2 Artemisinin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Artemisinin Distributors
- 9.2.3 Artemisinin Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst